Skip to main content
OpenTrials

Clinical trial condition

Recurrent Uterine Corpus Sarcoma

Explore clinical trials studying Recurrent Uterine Corpus Sarcoma. Study availability and eligibility vary by location and protocol.

11 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Recurrent Uterine Corpus Sarcoma trial results

Completed

Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer

NCT01168232

Conditions
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • John Muir Medical Center-Concord Campus Concord, California, United States
  • John Muir Medical Center-Walnut Creek Walnut Creek, California, United States
  • University of Colorado Hospital Aurora, Colorado, United States
View all 78 locations
View Trial Details
Completed

Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer

NCT01247571

Conditions
Recurrent Uterine Corpus Sarcoma, Uterine Carcinosarcoma
Locations
  • University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States
  • Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
View all 41 locations
View Trial Details
Completed

Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy

NCT01220609

Conditions
Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma
Locations
  • Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Los Angeles County-USC Medical Center Los Angeles, California, United States
  • USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
View all 72 locations
View Trial Details
Completed

Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus

NCT01637961

Conditions
Recurrent Uterine Corpus Sarcoma, Uterine Corpus Leiomyosarcoma
Locations
  • Hartford Hospital Hartford, Connecticut, United States
  • Smilow Cancer Hospital Care Center at Saint Francis Hartford, Connecticut, United States
  • The Hospital of Central Connecticut New Britain, Connecticut, United States
  • Florida Hospital Orlando Orlando, Florida, United States
View all 50 locations
View Trial Details
Completed

Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer

NCT01098630

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +28 more
Locations
  • Gynecologic Oncology Group of Arizona Phoenix, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • Providence Saint Joseph Medical Center/Disney Family Cancer Center Burbank, California, United States
  • Roy and Patricia Disney Family Cancer Center Burbank, California, United States
View all 167 locations
View Trial Details

Related conditions